HVC
ALKS icon

Healthcare Value Capital’s Alkermes ALKS Stock Holding History

Healthcare Value Capital’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3.08M Buy
+100,000
New +$2.83M 6.09% 5

Other funds holding ALKS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Healthcare Value Capital's ALKS Position: Q3 2021 in Review

Healthcare Value Capital reduced its Alkermes (ALKS) stake by 33% in Q3 2021, selling an estimated $1.41M and leaving 100,000 shares worth $3.08M. The position accounts for 6.09% of the portfolio, ranked #4.

Healthcare Value Capital first reported a position in ALKS in Q1 2021 and has held it in 3 quarters since. The position peaked at $3.68M in Q2 2021. 224 funds tracked by Wall St. Rank hold ALKS as of Q3 2021.

  • Healthcare Value Capital held 100,000 shares of Alkermes worth $3.08M as of Q3 2021.
  • Healthcare Value Capital sold 50,000 Alkermes shares in Q3 2021, an estimated $1.41M.
  • Alkermes made up 6.09% of Healthcare Value Capital's portfolio in Q3 2021, its #4 holding.
  • Healthcare Value Capital first reported a position in Alkermes in Q1 2021 and has held it in 3 quarters since.
  • Healthcare Value Capital's Alkermes position peaked at $3.68M in Q2 2021.
  • 224 funds tracked by Wall St. Rank held Alkermes as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.